Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 122c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($1.83), $1.22 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Stripe, Advent In Talks To Buy Paypal - WSJ
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results